WO2014044142A1 - Mycobacterium detection kit and method of use thereof - Google Patents

Mycobacterium detection kit and method of use thereof Download PDF

Info

Publication number
WO2014044142A1
WO2014044142A1 PCT/CN2013/083310 CN2013083310W WO2014044142A1 WO 2014044142 A1 WO2014044142 A1 WO 2014044142A1 CN 2013083310 W CN2013083310 W CN 2013083310W WO 2014044142 A1 WO2014044142 A1 WO 2014044142A1
Authority
WO
WIPO (PCT)
Prior art keywords
primer
reaction
mycobacterium
detection kit
mmol
Prior art date
Application number
PCT/CN2013/083310
Other languages
French (fr)
Chinese (zh)
Inventor
曹以诚
茅莉娜
陈振柳
杜正平
王静
吕冰凌
Original Assignee
广州华峰生物科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 广州华峰生物科技有限公司 filed Critical 广州华峰生物科技有限公司
Publication of WO2014044142A1 publication Critical patent/WO2014044142A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Definitions

  • the present invention relates to a biological detection reagent, and in particular to a Mycobacterium detection kit and a method of using the same. Background technique
  • Mycobacterium is a kind of slender, slightly curved bacillus with a tendency to grow branches, hence the name. There are many species of this genus, which can be divided into three groups: Mycobacterium tuberculosis complex, non-tuberculous mycobacteria and Mycobacterium leprae.
  • M. tuberculosis commonly known as Mycobacterium tuberculosis or tuberculosis, is the causative agent of tuberculosis. Tuberculosis is a major infectious disease that threatens human and animal health.
  • the World Health Organization (WHO) has issued a global TB control strategy and has designated March 24th as the World Tuberculosis Day.
  • Mycobacterium tuberculosis complex Corresponding to the Mycobacterium tuberculosis complex is a variety of non-tuberculous mycobacteria, hundreds of species have been found, widely found in soil, environment, and animals. According to the fourth national tuberculosis epidemiological sampling survey in 2000, there were 4.51 million active tuberculosis patients and 1.96 million patients with pulmonary tuberculosis. Among the positive cultures of mycobacteria, Mycobacterium tuberculosis accounted for 86.4%, Bovine Mycobacterium tuberculosis accounted for 2.5%, and nontuberculous mycobacteria accounted for 11.1%.
  • non-tuberculous mycobacteria In the third national tuberculosis epidemic in 1990, only non-tuberculous mycobacteria accounted for only 4.9 percent. This shows that the proportion of non-tuberculous mycobacteria is significantly higher than before.
  • Non-tuberculous mycobacteria patients are resistant to most first-line anti-tuberculosis drugs, and treatment with current standard chemotherapy regimens is ineffective.
  • Traditional mycobacterial strain identification and drug sensitivity test methods are based on culture, which is cumbersome and time-consuming. It takes 1-2 months to meet the needs of clinically effective early chemotherapy, making non-tuberculous mycobacteria patients long-term. Regular chemotherapy is not effective, the course of treatment is prolonged, and patients become refractory and retreated. Bacteria may spread locally.
  • PCR polymerase chain reaction
  • Fluorescence real-time quantitative polymerase chain reaction (real time PCR) technology solves the problem of cross-contamination and integrates the operation process, but it requires more complicated quantitative measurement instruments, so it is not suitable for rapid on-site detection. . Moreover, the cost of fluorescent probes in real-time quantitative polymerase chain reaction PCR technology is higher, which makes it more difficult to promote and apply. Immunological detection technology is fast and inexpensive, but requires high-quality and high-stability monoclonal antibodies. Otherwise, the accuracy is not enough. At present, it can only be an auxiliary detection method. Therefore, the timely application of the latest achievements in the development of biotechnology is of great significance to meet the continuous improvement of the requirements for detection of pathogenic microorganisms.
  • An object of the present invention is to provide a Mycobacterium detection kit which is more comprehensive, has high specificity, and has a low detection rate, which solves the deficiencies of the prior art.
  • a Mycobacterium detection kit wherein the Mycobacterium detection kit comprises a hsp65 gene of Mycobacterium as a target gene, based on a loop-mediated constant temperature expansion
  • Two pairs of primers designed by the technique: inner primer FIP/BIP and outer primer F3/B3, the two pairs of primers are
  • Primer F3 ( SEQ ID NO 1 )
  • External primer F3 ( SEQ ID NO 5 )
  • External primer B3 ( SEQ ID NO 6 )
  • V generation ⁇ A / C / G, R represents A / G.
  • the present invention is directed to a primer designed for the hsp65 gene of the genus Mycobacterium, which is a 65 kDa heat shock protein gene, which is highly conserved and widely present in each branching rod.
  • the primers are capable of amplifying and detecting all the species of the Mycobacterium tuberculosis complex and the non-tuberculous mycobacteria, including: M. tuberculosis, M. variabilis ( ⁇ Microti ), M. africanum, M. bovis, Mycobacterium kansii
  • the Mycobacterium test kit further comprises a DNA polymerase, a reaction solution, a stabilizing solution, a sample pretreatment solution, a color developing solution, and a positive control solution.
  • the polymerase enzyme concentration 4-10 ⁇ / ⁇ ⁇ ;
  • the reaction solution contains: 1.6 ⁇ 2mmol / L dNTP, 20 ⁇ 25mmol / L Tris-HCl, 10 ⁇ 12.5mmol / L KC1, 10 ⁇ 12.5mmol / L (NH 4 ) 2 S0 4 , 8 ⁇ lOmmol / L MgS0 4 , 0.1 ⁇ 0.125 vol% TritonX-100, 0.8 ⁇ lmol / L betaine;
  • the sample pretreatment liquid comprises: 10 - 20 mmol / L H 8.0 Tris-HCl, 1 ⁇ 2 mmol / L EDTA and 1 ⁇ 1.2 vol% Triton X-100;
  • the color developing solution is SYBR Green I or Eva Green
  • the stabilizing liquid is paraffin oil
  • the positive control is BCG genomic DNA
  • the internal primers FIP/BIP are each 0.2 to 0.25 mol/L, and the external primers F3/B3 are each 1.2 to 2.0 mol/L.
  • the fo DNA polymerase enzyme concentration 8 U / L;
  • the reaction solution contains: 2 mmol/L dNTP, 25 mmol/L Tris-HCl, 12.5 mmol/L KC1, 12.5 mmol/L (NH 4 ) 2 S0 4 , 10 mmol/L MgS0 4 , 0.125 vol% Triton X-100, Lmol/L betaine;
  • the sample pretreatment liquid comprises: 20 mmol/L Tris-HC1, pH 8.0, 2 mmol/L EDTA and 1.2% by volume Triton X-100;
  • the color developing solution is SYBR Green I;
  • the concentration of the internal primer FIP/BIP is 0.2 mol/L
  • the Mycobacterium detection kit further comprises a reaction tube, wherein the reaction tube is composed of a tube body and a tube cover, and the lower part of the tube body cavity A longitudinally extending partition is provided which divides it into two cavities A and B.
  • the two cavities A and B are respectively provided with a working liquid or a color developing liquid, and the upper layers of the liquid in both cavities are sealed by the stabilizing liquid.
  • the working fluid is a mixture of a reaction solution and a fo DNA polymerase.
  • Loop-mediated constant temperature amplification is a rapid, sensitive and accurate method for nucleic acid detection. Its amplification efficiency is super-excellent and manifests itself in two aspects: (1) Sensitivity is higher than PCR by an order of magnitude difference; (2) The amount of DNA of the amplified product is also much higher than that of the PCR product, which can reach several but too sensitive and the amount of the product is huge, making LAMP extremely susceptible to contamination, especially after the LAMP amplification reaction requires a reaction tube opening. Adding a developer to the cap is prone to aerosol contamination. Aerosol contamination can lead to high false positive rates and contaminate other samples, contaminate the detection area, and is difficult to remove.
  • the reaction tube of the invention effectively separates the color developing liquid from the working liquid through the design of the partition plate and the stabilizing liquid, which not only ensures relatively complete sealing during storage and transportation, but also can be opened without opening the tube cover. Achieve color reaction, greatly reducing aerosol pollution.
  • the invention also provides a method for using a Mycobacterium detection kit, the method comprising the following steps:
  • step (2) adding the precipitate of step (1) to the sample pretreatment liquid, mixing and hooking, inactivation of the boiling water bath, cooling on ice, centrifugation at high speed, and the supernatant is the sample template DNA;
  • the inner primer FIP/BIP and the outer primer F3/B3 in the step (3) are two pairs of primers designed based on the hsp65 gene of Mycobacterium and designed based on loop-mediated constant temperature amplification technology.
  • the reaction conditions of the constant temperature reaction are a temperature of 63 to 65 ° C and a reaction time of 45 to 90 min.
  • the method for rapidly detecting mycobacteria based on loop-mediated isothermal amplication of DNA (LAMP) according to the present invention is to use fo DNA polymerase and two pairs designed according to target gene sequences.
  • LAMP method is a kind of tube, fast Rapid, highly specific gene amplification method. Comparing the thermostatic gene amplification technology with PCR technology (including fluorescence real-time quantitative PCR), it can be found that the technology is equivalent to or superior to PCR technology in terms of sensitivity, specificity and detection range, and does not depend on any specialization.
  • the instrumentation can achieve high-throughput rapid detection in the field, and the detection cost is much lower than that of the real-time PCR technology.
  • the national standard is based on microbial isolation culture and morphological identification, combined with biochemical analysis and serological typing.
  • the preliminary identification takes 2 to 3 days, and the identification report takes 10 to 15 days.
  • the detection reagent of the present invention is used.
  • the box takes only 2 hours.
  • the color developing solution is added to the reaction system of the present invention, and the identification result is more intuitive and clear.
  • the invention has the following beneficial effects: 1.
  • the detection kit of the invention can amplify the reaction only by a constant temperature, does not require special reagents and equipment, and has low detection cost; 2.
  • the gene of the invention uses six segments, four primers, to determine whether the target substance is present or not depending on whether it is amplified, and thus has high specificity; 3.
  • the detection kit of the present invention is rapid and efficient in amplification, The amplification can be completed in 1 hour, and the yield is high; 4.
  • the detection kit of the invention has high sensitivity, and the amplification template only needs 10 copies or less; 5.
  • the gene rapid diagnostic kit of the invention identifies the cartridge, from The pyrophosphate ion precipitated by dNTP is combined with Mg 2+ in the reaction solution to produce a by-product, magnesium pyrophosphate precipitate, which can be identified by visual observation, and the color positive liquid has a significant difference in coloration after the addition of the color developing solution.
  • the detection kit of the present invention is more accurate in detecting Mycobacterium 7.
  • the special reaction tube is used in the detection kit of the invention, which reduces the possibility of aerosol contamination and is convenient to operate.
  • LAMP loop-mediated isothermal amplification, loop-mediated isothermal amplification
  • dNTP deoxyribonucleoside triphosphate, deoxynucleoside triacate
  • Bst enzyme Bst DNA polymerase (large fragment)
  • Bst DNA polymerase large fragment
  • EDTA ethylenediamine tetraacetic acid, ethylenediaminetetraacetic acid
  • DNA deoxyribonucleic acid, deoxyribonucleic acid
  • Triton X-100 Polyethylene glycol octyl phenyl ether
  • Hsp65 65 kDa heat shock protein
  • reaction solution contained 2 mmol/L dNTP, 25 mmol/L Tris-CK 12.5 mmol/L KC1, 12.5 mmol/L (NH 4 ) 2 S0 4 , 10 mmol/L MgS0 4 , 0.125 vol% TritonX -100, lmol/L betaine, internal primer FIP/BIP 0.2 mol/L and external primer F3/B3 each 0.25 mol/L, placed in a container;
  • the sample pretreatment liquid contains 20 mmol/L Tris-HC1 (pH 8.0), 2 mmol/L EDTA and 1.2% by volume Triton X-100, and placed in a container;
  • the preparation process is as follows:
  • the liquid prepared in the above steps (2) to (4) is aseptically packaged, and the concentration is determined according to the experiment, and the sample quality inspection is performed;
  • reaction solution contains 1.6 mmol/L dNTP, 20 mmol/L Tris-Cl, 1 Ommol/L KCl, 1 Ommol/L (NH 4 ) 2 S0 4 , 8 mmol/L MgS0 4 , 0.1 volume % TritonX-100, 0.8 mol/L betaine, internal primer FIP/BIP 0.2 mol/L and external primer F3/B3 each 0.25 mol/L, placed in the valley;
  • Preparing sample pretreatment liquid contains 10 mmol/L Tris-HCl (pH 8.0), mmol/L EDTA and 1.0% by volume Triton X-100, and placed in a container;
  • Extracting the positive control extracting the BCG genomic DNA and placing it in a container;
  • primers in the step (1) are:
  • External primer F3 ( SEQ ID NO 5 )
  • External primer B3 ( SEQ ID NO 6 )
  • primers in the step (1) are:
  • the invention adopts 29 strains, mainly from the American Standard Biological Collection Center and the China National Institute for the Control of Pharmaceutical and Biological Products. See Table 1 for details.
  • M.chelonae ATCC 14472
  • M.fortuitum ATCC 6841
  • M. gordonae ATCC 14470
  • M.marinum ATCC 927
  • M.smegmatis ATCC
  • M.asiaticum ATCC 25276
  • M.xenopi ATCC 19250
  • strains of Staphylococcus aureus Shigella, Vibrio parahaemolyticus, Salmonella, mononuclear hyperplasia Listeria monocytogenes, Yersinia enterocolitica, and one strain of Streptococcus hemolyticus.
  • reaction system in 20 ( ⁇ L reaction tube: 22 L of reaction solution and primer, 0.5 ⁇ (4U) of fo DNA polymerase, 30 ⁇ of stable solution, 2.5 L of template DNA.
  • the M. bovis BCG was extracted from the nucleic acid, and the LAMP assay was performed by serially diluting to 10 ⁇ 1() with a 10-fold ratio of TE. 8. The repeatability test specificity test and sensitivity test were repeated twice. Second, the results 1, specificity test
  • M.ulcerans ATCC 19423
  • M.shimoidei ATCC 27962
  • the concentration of the bacterial stock solution was 1.26 ⁇ 10 6 CFU/mL, and the fourth dilution was detected by the LAMP method, which was 1.26 ⁇ 10 2 CFU/mL.
  • Example 6 Mycobacterium detection kit using a reaction tube
  • the Mycobacterium detection kit of the present embodiment has the same reagents and primers as in Example 1, and the reagent cartridge further includes a reaction tube, and the reaction tube is composed of a tube body and The tube cover is composed of two parts, and the lower part of the inner cavity of the tube is provided with a longitudinally extending partition which divides the two cavities into A and B, wherein: the cavity A is filled with 22.0 ⁇ The LAMP reaction solution and 0.5 ⁇ M of Bst DNA polymerase, the upper layer of the liquid is sealed by paraffin; the cavity B contains 2.0 ⁇ M of LAMP reaction coloring solution, and the upper liquid layer is also sealed by paraffin, and the reaction tube is stored at -20 ° C.
  • the reaction tube is used as a container, and the LAMP test is performed on the Mycobacterium, and the positive control group and the negative control group are provided at the same time, and the following steps are specifically included:
  • the three reaction tubes prepared above are taken, and the pipettes are respectively added to the negative cells.
  • the control sample, the sample to be tested and the positive control sample each are 2.5 ⁇ .
  • the tip of the sample penetrates the protective layer, and the sample is added into the cavity of the reaction tube.
  • the tube cap is tightly covered and marked, and moved to the reaction zone.
  • the above reaction tubes were all reacted at 65 ° C for 1 h.
  • reaction tube was inverted and shaken once, and then placed upright once, and the working solution and the color developing solution were thoroughly mixed and observed. If the reaction tube is green as the positive control tube, it is positive, and if the reaction tube is orange as the negative control tube, it is negative.
  • the color developing solution and the working fluid are in a sealed state, and no mutual leakage occurs.
  • the inverted turbulent operation causes the coloring liquid and the working fluid to be mixed, and the coloration result is clear.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Provided is a mycobacterium detection kit, the kit comprising two pairs of primers designed by using the hsp65 gene of the mycobacterium as a target gene based on a loop-mediated isothermal amplification technology: an inner primer FIP/BIP and an outer primer F3/B3. Also provided is a method of use for the mycobacterium detection kit.

Description

分枝杆菌属检测试剂盒及其使用方法 技术领域 本发明涉及生物检测试剂, 具体涉及一种分枝杆菌属检测试剂盒及其使用 方法。 背景技术  TECHNICAL FIELD The present invention relates to a biological detection reagent, and in particular to a Mycobacterium detection kit and a method of using the same. Background technique
分枝杆菌属 (Mycobacterium )是一类细长略带弯曲的杆菌, 有分枝生长的 趋势, 因而得名。 本菌属种类较多, 可分为结核分枝杆菌复合群、 非结核分 枝杆菌和麻风分枝杆菌三类。  Mycobacterium is a kind of slender, slightly curved bacillus with a tendency to grow branches, hence the name. There are many species of this genus, which can be divided into three groups: Mycobacterium tuberculosis complex, non-tuberculous mycobacteria and Mycobacterium leprae.
结核分枝杆菌 (M.tuberculosis ), 俗称结核杆菌或结核菌, 是引起结核 病的病原菌。 结核病是威胁人类及动物健康的重大传染病。世界卫生组织 (WHO) 专门发布了全球结核控制战略, 并把每年的 3月 24号定为世界防治结核病日。  M. tuberculosis, commonly known as Mycobacterium tuberculosis or tuberculosis, is the causative agent of tuberculosis. Tuberculosis is a major infectious disease that threatens human and animal health. The World Health Organization (WHO) has issued a global TB control strategy and has designated March 24th as the World Tuberculosis Day.
与结核分枝杆菌复合群对应的是各种非结核分枝杆菌, 目前已发现上百种, 广泛存在于土壤、 环境、 动物中。 2000年第四次全国结核病流行病学抽样调查 报告显示, 我国现有活动性肺结核患者 451万, 菌阳肺结核患者 196万。 分枝 杆菌培养阳性者中, 结核分枝杆菌占 86.4%, 牛结核分枝杆菌占 2.5%, 非结核 分枝杆菌占 11.1%。 而 1990年第三次全国结核病流调时非结核分枝杆菌仅占 4. 9%, 由此可见, 非结核分枝杆菌的比率较前明显增加。 非结核分枝杆菌患者对 大多数一线抗结核药物耐药, 采用目前标准的化疗方案治疗无效。 传统的分枝 杆菌菌种鉴定和药敏实验方法建立在培养基础上,烦瑣、 费时, 需 1 ~ 2月时间, 不能满足临床开展早期有效化疗的需要, 使非结核分枝杆菌患者经长期规则化 疗而疗效不佳, 疗程延长, 成为难治、 复治患者, 细菌可能在局部播散。 因此, 分枝杆菌属的快速鉴定对结核病及非结核分枝杆菌病的早期诊断、 鉴别诊断、 有效化疗和控制传播都有极其重要的意义。 传统分枝杆菌检测方法, 由于其检测周期长、 程序复杂、 所需试剂繁多等 缺点已远远不能满足现代检测要求。 以聚合酶链式反应 ( PCR )技术为代表的病 原核酸检测技术在实际应用中存在一些问题, 如普通聚合酶链式反应(PCR )技 术需要专门的仪器, 而且存在容易交叉污染和操作过程烦瑣的缺点。 而荧光实 时定量聚合酶链式反应 ( real time PCR )技术虽然较好地解决了交叉污染的问 题, 并筒化了操作过程, 但却需要更复杂的定量测定仪器, 因此不适用于现场 快速检测。 而且实时定量聚合酶链式反应 PCR技术中荧光探针的成本较高, 加 大了推广应用的难度。 免疫学检测技术快速筒便成本低廉, 但要求高质量高稳 定性的单克隆抗体, 否则因准确性不够, 目前只能是辅助检测手段。 所以及时 运用生物技术发展的最新成果对满足病原微生物检测要求的不断提高具有重要 意义。 其中恒温扩增 (Isothermal Amplification )核酸快速检测技术是病原核酸 检测技术上的长足进步, 现已建立起来的环介导恒温扩增技术(LAMP )具有很 多的优越性。 因此, 需要一种检测效果更全面、 特异性高、 漏检率低的分枝杆菌属检测 试剂盒及其使用方法以解决上述问题。 发明内容 本发明的目的在于解决现有技术的不足之处而提供一种检测效果更全面、 特异性高、 漏检率低的分枝杆菌属检测试剂盒。 本发明的目的可以通过以下技术措施实现: 一种分枝杆菌属检测试剂盒, 所述的分枝杆菌属检测试剂盒包括以分枝杆菌属的 hsp65基因为靶基因、基于环 介导恒温扩增技术设计的两对引物: 内引物 FIP/BIP和外引物 F3/B3 , 所述的两 对引物为 Corresponding to the Mycobacterium tuberculosis complex is a variety of non-tuberculous mycobacteria, hundreds of species have been found, widely found in soil, environment, and animals. According to the fourth national tuberculosis epidemiological sampling survey in 2000, there were 4.51 million active tuberculosis patients and 1.96 million patients with pulmonary tuberculosis. Among the positive cultures of mycobacteria, Mycobacterium tuberculosis accounted for 86.4%, Bovine Mycobacterium tuberculosis accounted for 2.5%, and nontuberculous mycobacteria accounted for 11.1%. In the third national tuberculosis epidemic in 1990, only non-tuberculous mycobacteria accounted for only 4.9 percent. This shows that the proportion of non-tuberculous mycobacteria is significantly higher than before. Non-tuberculous mycobacteria patients are resistant to most first-line anti-tuberculosis drugs, and treatment with current standard chemotherapy regimens is ineffective. Traditional mycobacterial strain identification and drug sensitivity test methods are based on culture, which is cumbersome and time-consuming. It takes 1-2 months to meet the needs of clinically effective early chemotherapy, making non-tuberculous mycobacteria patients long-term. Regular chemotherapy is not effective, the course of treatment is prolonged, and patients become refractory and retreated. Bacteria may spread locally. Therefore, the rapid identification of Mycobacterium is extremely important for early diagnosis, differential diagnosis, effective chemotherapy and controlled transmission of tuberculosis and non-tuberculous mycobacterial diseases. The traditional mycobacterial detection method is far from meeting the modern detection requirements due to its short detection period, complicated procedures, and numerous reagents required. Pathogenic nucleic acid detection technology represented by polymerase chain reaction (PCR) technology has some problems in practical applications. For example, common polymerase chain reaction (PCR) technology requires specialized instruments, and there are easy cross-contamination and annoying operation. Trivial shortcomings. Fluorescence real-time quantitative polymerase chain reaction (real time PCR) technology solves the problem of cross-contamination and integrates the operation process, but it requires more complicated quantitative measurement instruments, so it is not suitable for rapid on-site detection. . Moreover, the cost of fluorescent probes in real-time quantitative polymerase chain reaction PCR technology is higher, which makes it more difficult to promote and apply. Immunological detection technology is fast and inexpensive, but requires high-quality and high-stability monoclonal antibodies. Otherwise, the accuracy is not enough. At present, it can only be an auxiliary detection method. Therefore, the timely application of the latest achievements in the development of biotechnology is of great significance to meet the continuous improvement of the requirements for detection of pathogenic microorganisms. Among them, the rapid detection technology of Isothermal Amplification is a great progress in the detection of pathogenic nucleic acid, and the ring-mediated constant temperature amplification technology (LAMP) has been established has many advantages. Therefore, there is a need for a Mycobacterium detection kit having a more comprehensive detection effect, a high specificity, and a low detection rate, and a method of using the same to solve the above problems. SUMMARY OF THE INVENTION An object of the present invention is to provide a Mycobacterium detection kit which is more comprehensive, has high specificity, and has a low detection rate, which solves the deficiencies of the prior art. The object of the present invention can be achieved by the following technical measures: A Mycobacterium detection kit, wherein the Mycobacterium detection kit comprises a hsp65 gene of Mycobacterium as a target gene, based on a loop-mediated constant temperature expansion Two pairs of primers designed by the technique: inner primer FIP/BIP and outer primer F3/B3, the two pairs of primers are
夕卜引物 F3: ( SEQ ID NO 1 )  夕卜 Primer F3: ( SEQ ID NO 1 )
TCATCACCGTCGAGGAGTC 外引物 B3: ( SEQ ID NO 2 ) TCATCACCGTCGAGGAGTC External primer B3: ( SEQ ID NO 2 )
CGGCTCCGATGACCTTCTC  CGGCTCCGATGACCTTCTC
内引物 FIP: ( SEQ ID NO 3 )  Internal primer FIP: ( SEQ ID NO 3 )
GTCGGTCACGAAGTACCC  GTCGGTCACGAAGTACCC
内引物 BIP: ( SEQ ID NO 4 )  Internal primer BIP: ( SEQ ID NO 4 )
AGCGTCAGGAGGCVGTCCTTGACAGTGGACACCTTGGAG;  AGCGTCAGGAGGCVGTCCTTGACAGTGGACACCTTGGAG;
 Or
外引物 F3,: ( SEQ ID NO 5 )  External primer F3,: ( SEQ ID NO 5 )
AGTCCATCGGTGACCTGATC  AGTCCATCGGTGACCTGATC
外引物 B3,: ( SEQ ID NO 6 )  External primer B3,: ( SEQ ID NO 6 )
AGGACCGCCTCCTGAC  AGGACCGCCTCCTGAC
内引物 FIP,: ( SEQ ID NO 7 )  Internal primer FIP,: ( SEQ ID NO 7 )
GGTGTTGGACTCCTCGACGGGCCGAGGCGATGGACAA  GGTGTTGGACTCCTCGACGGGCCGAGGCGATGGACAA
内引物 BIP,: ( SEQ ID NO 8 )  Internal primer BIP,: ( SEQ ID NO 8 )
GCAGCTCGAGCTCACCGAGCGGGTCGGTCACGAAGT;  GCAGCTCGAGCTCACCGAGCGGGTCGGTCACGAAGT;
 Or
外引物 F3": ( SEQ ID NO 1 )  External primer F3": ( SEQ ID NO 1 )
TCATCACCGTCGAGGAGTC  TCATCACCGTCGAGGAGTC
外引物 B3": ( SEQ ID NO 9 )  External primer B3": ( SEQ ID NO 9 )
AGCGGCAGCAGRTCCT  AGCGGCAGCAGRTCCT
内引物 FIP": ( SEQ ID NO 10 ) 内引物 BIP": ( SEQ ID NO 4 )  Internal primer FIP": (SEQ ID NO 10 ) internal primer BIP": ( SEQ ID NO 4 )
AGCGTCAGGAGGCVGTCCTTGACAGTGGACACCTTGGAG;  AGCGTCAGGAGGCVGTCCTTGACAGTGGACACCTTGGAG;
其中, V代^ A/C/G, R代表 A/G。  Among them, V generation ^ A / C / G, R represents A / G.
本发明针对分枝杆菌属的 hsp65基因设计引物,所述 hsp65基因为 65 kDa热休 克蛋白 (heat shock protein )基因, 由于该基因高度保守并广泛存在于各分枝杆 菌属菌种中, 因此其引物能够扩增并检测出结核分枝杆菌复合群及非结核分枝 杆菌所有菌种,包括:结核分枝杆菌(M.tuberculosis )、田鼠分枝杆菌( Μ· microti )、 非洲分枝杆菌 ( M.africanum )、 牛分枝杆菌 ( M.bovis )、 堪萨斯分枝杆菌The present invention is directed to a primer designed for the hsp65 gene of the genus Mycobacterium, which is a 65 kDa heat shock protein gene, which is highly conserved and widely present in each branching rod. Among the species of the genus, the primers are capable of amplifying and detecting all the species of the Mycobacterium tuberculosis complex and the non-tuberculous mycobacteria, including: M. tuberculosis, M. variabilis (Μ· Microti ), M. africanum, M. bovis, Mycobacterium kansii
( M.kansasii )、 胞内分枝杆菌 ( M.intracellulare )、 龟分枝杆菌 ( M. chelonae )、 偶发分枝杆菌 ( M.fortuitum )、 戈登分枝杆菌 ( M.gordonae )、 海分枝杆菌(M.kansasii), M. intracellulare, M. chelonae, M. fortuitum, M. gordonae, sea Mycobacterium
( M.marinum )、 耻垢分枝杆菌 ( M.smegmatis )、 土分枝杆菌 (M.terrae )、 鸟分 枝杆菌 ( M. avium )、 草分枝杆菌 (M.phlei )、 瘰疠分枝杆菌 ( M.scrofulaceum )、 脓肿分枝杆菌 (M.abscessus ) , 溃疡分枝杆菌 ( M.ulcerans )、 施氏分枝杆菌(M.marinum), M. smegmatis, M. terrae, M. avium, M. phlei, 瘰疠M. scrofulaceum, M. abscessus, M. ulcerans, Mycobacterium tuberculosis
( M.shimoidei )、 亚洲分枝杆菌( M.asiaticum )、 蟾虫余分枝杆菌( M.xenopi )、 胃 分枝杆菌 (M.gastri ) 。 作为本发明分枝杆菌属检测试剂盒的优选实施方式, 所述的分枝杆菌属检 测试剂盒还包括 DNA聚合酶、 反应液、 稳定液、 样品预处理液、 显色液和 阳性对照液。 作为本发明分枝杆菌属检测试剂盒的更优选实施方式, (M. shimoidei), M. asiaticum, M. xenopi, M. gastri. As a preferred embodiment of the Mycobacterium detection kit of the present invention, the Mycobacterium test kit further comprises a DNA polymerase, a reaction solution, a stabilizing solution, a sample pretreatment solution, a color developing solution, and a positive control solution. As a more preferred embodiment of the Mycobacterium detection kit of the present invention,
所述的 聚合酶: 酶浓度 4-10 υ/μΐ^;  The polymerase: enzyme concentration 4-10 υ / μΐ ^;
所述的反应液含: 1.6 ~ 2mmol/L dNTP、 20 ~ 25mmol/L Tris-HCl、 10 ~ 12.5mmol/L KC1、 10 ~ 12.5mmol/L ( NH4 ) 2S04、 8 ~ lOmmol/L MgS04、 0.1 ~ 0.125体积 % TritonX-100 , 0.8 ~ lmol/L甜菜碱; The reaction solution contains: 1.6 ~ 2mmol / L dNTP, 20 ~ 25mmol / L Tris-HCl, 10 ~ 12.5mmol / L KC1, 10 ~ 12.5mmol / L (NH 4 ) 2 S0 4 , 8 ~ lOmmol / L MgS0 4 , 0.1 ~ 0.125 vol% TritonX-100, 0.8 ~ lmol / L betaine;
所述的样品预处理液含: 10 - 20 mmol/L H 8.0的 Tris-HCl、 1 ~ 2 mmol/L EDTA和 1 ~ 1.2体积% Triton X-100;  The sample pretreatment liquid comprises: 10 - 20 mmol / L H 8.0 Tris-HCl, 1 ~ 2 mmol / L EDTA and 1 ~ 1.2 vol% Triton X-100;
所述的显色液为 SYBR Green I或 Eva Green;  The color developing solution is SYBR Green I or Eva Green;
所述稳定液为石蜡油;  The stabilizing liquid is paraffin oil;
所述的阳性对照为 BCG基因组 DNA;  The positive control is BCG genomic DNA;
所述的内引物 FIP/BIP各为 0.2 ~ 0.25 mol/L,外引物 F3/B3的浓度各为 1.2 ~ 2.0 mol/L。 作为本发明分枝杆菌属检测试剂盒的最优选实施方式, The internal primers FIP/BIP are each 0.2 to 0.25 mol/L, and the external primers F3/B3 are each 1.2 to 2.0 mol/L. As a most preferred embodiment of the Mycobacterium detection kit of the present invention,
所述的 fo DNA聚合酶: 酶浓度 8 U/ L;  The fo DNA polymerase: enzyme concentration 8 U / L;
所述的反应液含: 2mmol/L dNTP、 25mmol/L Tris-HCl、 12.5mmol/L KC1、 12.5mmol/L ( NH4 ) 2S04, lOmmol/L MgS04、 0.125体积% TritonX-100、 lmol/L甜菜碱; The reaction solution contains: 2 mmol/L dNTP, 25 mmol/L Tris-HCl, 12.5 mmol/L KC1, 12.5 mmol/L (NH 4 ) 2 S0 4 , 10 mmol/L MgS0 4 , 0.125 vol% Triton X-100, Lmol/L betaine;
所述的样品预处理液含: 20 mmol/L pH 8.0的 Tris- HC1、 2 mmol/L EDTA和 1.2体积% Triton X-100;  The sample pretreatment liquid comprises: 20 mmol/L Tris-HC1, pH 8.0, 2 mmol/L EDTA and 1.2% by volume Triton X-100;
所述的显色液为 SYBR Green I;  The color developing solution is SYBR Green I;
所述的内引物 FIP/BIP的浓度为 0.2 mol/L;  The concentration of the internal primer FIP/BIP is 0.2 mol/L;
所述的外引物 F3/B3的浓度为 1.6 mol/L。 作为本发明分枝杆菌属检测试剂盒的优选实施方式, 所述的分枝杆菌属检 测试剂盒还包括反应管, 所述的反应管由管体和管盖两部分组成, 管体内腔的 下部设有将其分隔成 A、 B两个空腔的纵向延伸的隔板。 作为本发明分枝杆菌属检测试剂盒的更优选实施方式, 所述的 A、 B两个 空腔中分别装有工作液或显色液, 两个空腔中的液体上层均由稳定液封存, 所 述工作液为反应液和 fo DNA聚合酶的混合而成。 环介导恒温扩增技术(LAMP )是一种快速、 灵敏、 准确的核酸检测方式, 其扩增效率超强, 表现在两个方面: ( 1 ) 灵敏度比 PCR高出的是数量级的差 异; (2 )扩增产物的 DNA数量, 也比 PCR产物高出太多, 能够达到几个 但过于灵敏和产物量的巨大, 使得 LAMP极其容易污染, 尤其是在 LAMP扩增 反应后需要反应管开盖加入显色剂, 容易出现气溶胶污染。 而气溶胶污染会使 得检测结果假阳性率高, 并且污染其他样品, 污染检测区域, 同时还难以去 除。 本发明的反应管通过隔板和稳定液的设计, 有效地将显色液和工作液分隔 开来, 不仅能保证在储运过程中相对保持完整封闭性, 而且无需打开管盖, 就 可以实现显色反应, 大大降低气溶胶的污染。 本发明还提供一种分枝杆菌属检测试剂盒的使用方法, 该方法包括如下步 骤: The concentration of the external primer F3/B3 was 1.6 mol/L. As a preferred embodiment of the Mycobacterium detection kit of the present invention, the Mycobacterium detection kit further comprises a reaction tube, wherein the reaction tube is composed of a tube body and a tube cover, and the lower part of the tube body cavity A longitudinally extending partition is provided which divides it into two cavities A and B. As a more preferred embodiment of the Mycobacterium detection kit of the present invention, the two cavities A and B are respectively provided with a working liquid or a color developing liquid, and the upper layers of the liquid in both cavities are sealed by the stabilizing liquid. The working fluid is a mixture of a reaction solution and a fo DNA polymerase. Loop-mediated constant temperature amplification (LAMP) is a rapid, sensitive and accurate method for nucleic acid detection. Its amplification efficiency is super-excellent and manifests itself in two aspects: (1) Sensitivity is higher than PCR by an order of magnitude difference; (2) The amount of DNA of the amplified product is also much higher than that of the PCR product, which can reach several but too sensitive and the amount of the product is huge, making LAMP extremely susceptible to contamination, especially after the LAMP amplification reaction requires a reaction tube opening. Adding a developer to the cap is prone to aerosol contamination. Aerosol contamination can lead to high false positive rates and contaminate other samples, contaminate the detection area, and is difficult to remove. The reaction tube of the invention effectively separates the color developing liquid from the working liquid through the design of the partition plate and the stabilizing liquid, which not only ensures relatively complete sealing during storage and transportation, but also can be opened without opening the tube cover. Achieve color reaction, greatly reducing aerosol pollution. The invention also provides a method for using a Mycobacterium detection kit, the method comprising the following steps:
( 1 )将待测样品离心, 去上清, 得到沉淀;  (1) centrifuging the sample to be tested, removing the supernatant to obtain a precipitate;
( 2 )将步骤(1 ) 的沉淀加入样品预处理液, 混合均勾, 沸水浴灭活后冰 上冷却, 高速离心, 上清即为样品模板 DNA;  (2) adding the precipitate of step (1) to the sample pretreatment liquid, mixing and hooking, inactivation of the boiling water bath, cooling on ice, centrifugation at high speed, and the supernatant is the sample template DNA;
( 3 )在反应容器中加入 Bst DNA聚合酶 0.9 - 1.8体积份数、 反应液 38~40 体积份数、 稳定液 52 ~ 54.5体积份数、 样品模板 DNA 4.5-9体积份数、 内引物 FIP/BIP各 2体积份数、 外引物 F3/B3各 4体积份数, 恒温反应;  (3) Adding 0.9 to 1.8 parts by volume of Bst DNA polymerase, 38 to 40 parts by volume of the reaction solution, 52 to 54.5 parts by volume of the stable solution, 4.5-9 parts by volume of the sample template DNA, and FIP of the internal primer in the reaction vessel /BIP 2 parts by volume, 4 parts by volume of external primer F3/B3, constant temperature reaction;
( 4 )在上述反应容器和阳性对照中分别加入显色液, 混匀, 样品组显色与 对照组相同则为阳性, 否则为阴性;  (4) adding a coloring solution to the above reaction container and the positive control, respectively, and mixing, and the color of the sample group is positive as the control group, otherwise it is negative;
所述步骤( 3 )中的内引物 FIP/BIP和外引物 F3/B3为以分枝杆菌属的 hsp65 基因为靶基因、 基于环介导恒温扩增技术设计的两对引物。 作为本发明使用分枝杆菌属检测试剂盒的方法的优选实施方式, 步骤(3 ) 中, 恒温反应的反应条件为温度 63 ~ 65 °C , 反应时间 45 ~ 90min。 本发明所说的基于环介导恒温扩增技术 ( loop-mediated isothermal amplication of DNA, 筒称 LAMP )快速检测分枝杆菌属的方法, 是利用 fo DNA 聚合酶和根据靶基因序列设计的两对特殊的内、 外引物 (即内引物 FIP/BIP和外 引物 F3/B3 ), 特异性识别靶序列上的六个独立区域, 启动循环链置换反应, 在 靶标 DNA区启动互补链合成, 结果在同一链上互补序列周而复始形成有 4艮多环 的花椰菜结构的茎-环 DNA混合物。 LAMP反应过程中, 从 dNTP析出的焦磷酸 根离子与反应溶液中的 Mg2+结合, 产生副产物——焦磷酸镁乳白色沉淀, 即可 通过肉眼观察判定结果。 LAMP反应是在恒温( 63 ~ 65 °C )条件下 45 ~ 90分钟 内完成。 这种比较温和的温度条件以及没有温度循环使所需仪器筒单化, 克服 了传统 PCR固有的检测时间长、 容易污染及检测成本高等缺点。 此外, 这种检测 方法对检测人员的技术素质要求较低, 实际操作极为筒便, 不需要特殊的试剂 和仪器设备, 有利于建立成本低廉的快速筛选体系。 LAMP 法是一种筒便、 快 速、 高度特异性的基因扩增法。 将恒温基因扩增技术与 PCR技术(包括荧光实时 定量 PCR技术)进行比较, 可以发现该技术在灵敏度、特异性和检测范围等方法 学指标上相当于或优于 PCR技术,且不依赖任何专门的仪器设备即可实现现场高 通量快速检测, 而且检测成本远低于荧光定量 PCR技术。 目前国家标准中以微生 物分离培养和形态学鉴定为主、 结合生化分析和血清学分型鉴定的通行方法, 初步鉴定需 2 ~ 3天, 完成鉴定报告需 10 ~ 15天; 采用本发明的检测试剂盒仅 需 2小时。 并且, 本发明的反应体系中加入了显色液, 鉴定结果更为直观清晰。 与现有技术相比, 本发明具有如下有益效果: 1.本发明的检测试剂盒只需一 个恒定温度就能扩增反应, 不需要特殊试剂与设备, 检测成本低; 2.本发明的基 因快速诊断试剂盒应用六个区段, 四条引物, 根据是否扩增就能判断靶标物质 的存在与否, 因此具有高特异性; 3.本发明的检测试剂盒扩增快速且高效, 在不 到 1小时即可完成扩增, 且产率高; 4.本发明的检测试剂盒灵敏度高, 扩增模板 仅需 10拷贝或更少; 5.本发明的基因快速诊断试剂盒鉴定筒便, 从 dNTP析出 的焦磷酸根离子与反应溶液中的 Mg2+结合, 产生副产物——焦磷酸镁沉淀, 可 通过肉眼观察鉴定, 并且加入显色液后, 阴阳性结果显色差异显著, 验证率高, 更加明显可靠; 6.由于选择了高保守性的 hsp65基因作为靶基因设计引物, 使得 本发明的检测试剂盒检测分枝杆菌属的准确率更高; 7.在本发明检测试剂盒中采 用特制的反应管, 减少了气溶胶污染的可能性, 同时方便操作。 具体实施方式 为使本发明更加容易理解, 下面将进一步阐述本发明的具体实施例。 下列缩略语适用于本发明: The inner primer FIP/BIP and the outer primer F3/B3 in the step (3) are two pairs of primers designed based on the hsp65 gene of Mycobacterium and designed based on loop-mediated constant temperature amplification technology. As a preferred embodiment of the method of using the Mycobacterium detection kit of the present invention, in the step (3), the reaction conditions of the constant temperature reaction are a temperature of 63 to 65 ° C and a reaction time of 45 to 90 min. The method for rapidly detecting mycobacteria based on loop-mediated isothermal amplication of DNA (LAMP) according to the present invention is to use fo DNA polymerase and two pairs designed according to target gene sequences. Special internal and external primers (ie, internal primer FIP/BIP and external primer F3/B3) specifically recognize six independent regions on the target sequence, initiate cyclical chain displacement reaction, and initiate complementary strand synthesis in the target DNA region. The complementary sequence on the same strand is repeatedly formed into a stem-loop DNA mixture of a 4-inch polycyclic broccoli structure. During the LAMP reaction, the pyrophosphate ion precipitated from the dNTP is combined with Mg 2+ in the reaction solution to produce a white precipitate of the magnesium pyrophosphate, which is a by-product, and the result can be visually observed. The LAMP reaction is completed within 45 to 90 minutes at a constant temperature (63 ~ 65 °C). This relatively mild temperature condition and the absence of temperature cycling simplify the required instrumentation, overcoming the shortcomings of traditional PCR, such as long detection time, easy contamination, and high detection cost. In addition, this kind of detection method has low requirements on the technical quality of the inspectors, and the actual operation is extremely convenient, and no special reagents and instruments are needed, which is conducive to establishing a low-cost rapid screening system. LAMP method is a kind of tube, fast Rapid, highly specific gene amplification method. Comparing the thermostatic gene amplification technology with PCR technology (including fluorescence real-time quantitative PCR), it can be found that the technology is equivalent to or superior to PCR technology in terms of sensitivity, specificity and detection range, and does not depend on any specialization. The instrumentation can achieve high-throughput rapid detection in the field, and the detection cost is much lower than that of the real-time PCR technology. At present, the national standard is based on microbial isolation culture and morphological identification, combined with biochemical analysis and serological typing. The preliminary identification takes 2 to 3 days, and the identification report takes 10 to 15 days. The detection reagent of the present invention is used. The box takes only 2 hours. Moreover, the color developing solution is added to the reaction system of the present invention, and the identification result is more intuitive and clear. Compared with the prior art, the invention has the following beneficial effects: 1. The detection kit of the invention can amplify the reaction only by a constant temperature, does not require special reagents and equipment, and has low detection cost; 2. The gene of the invention The rapid diagnostic kit uses six segments, four primers, to determine whether the target substance is present or not depending on whether it is amplified, and thus has high specificity; 3. The detection kit of the present invention is rapid and efficient in amplification, The amplification can be completed in 1 hour, and the yield is high; 4. The detection kit of the invention has high sensitivity, and the amplification template only needs 10 copies or less; 5. The gene rapid diagnostic kit of the invention identifies the cartridge, from The pyrophosphate ion precipitated by dNTP is combined with Mg 2+ in the reaction solution to produce a by-product, magnesium pyrophosphate precipitate, which can be identified by visual observation, and the color positive liquid has a significant difference in coloration after the addition of the color developing solution. High, more obvious and reliable; 6. Due to the selection of the highly conserved hsp65 gene as a target gene design primer, the detection kit of the present invention is more accurate in detecting Mycobacterium 7. The special reaction tube is used in the detection kit of the invention, which reduces the possibility of aerosol contamination and is convenient to operate. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS In order to make the present invention easier to understand, specific embodiments of the present invention will be further described below. The following abbreviations apply to the present invention:
LAMP: loop-mediated isothermal amplification, 环介导恒温扩增  LAMP: loop-mediated isothermal amplification, loop-mediated isothermal amplification
dNTP: deoxyribonucleoside triphosphate , 脱氧核苷三騎酸  dNTP: deoxyribonucleoside triphosphate, deoxynucleoside triacate
Bst酶: Bst DNA polymerase (large fragment) , Bst DNA聚合酶(大片段) EDTA: ethylenediamine tetraacetic acid, 乙二胺四乙酸 Bst enzyme: Bst DNA polymerase (large fragment), Bst DNA polymerase (large fragment) EDTA: ethylenediamine tetraacetic acid, ethylenediaminetetraacetic acid
DNA: deoxyribonucleic acid, 脱氧核糖核酸  DNA: deoxyribonucleic acid, deoxyribonucleic acid
Betaine: 甜菜械  Betaine: Beet
Triton X-100: 聚乙二醇辛基苯基醚  Triton X-100: Polyethylene glycol octyl phenyl ether
hsp65: 65 kDa热休克蛋白  Hsp65: 65 kDa heat shock protein
BCG: 卡介苗 实施例 1 试剂盒的制备  BCG: BCG vaccine Example 1 Preparation of kit
( 1 )按以下序列经 DNA合成仪合成寡聚脱氧核酸引物:  (1) Synthesis of oligodeoxynucleotide primers by DNA synthesizer according to the following sequence:
夕卜引物 F3: (SEQIDNO 1 )  夕卜引器 F3: (SEQIDNO 1 )
TCATCACCGTCGAGGAGTC  TCATCACCGTCGAGGAGTC
外引物 B3: (SEQIDNO 2)  External primer B3: (SEQIDNO 2)
CGGCTCCGATGACCTTCTC  CGGCTCCGATGACCTTCTC
内引物 FIP: (SEQIDNO 3) 内引物 BIP: (SEQIDNO 4)  Internal primer FIP: (SEQIDNO 3) Internal primer BIP: (SEQIDNO 4)
AGCGTCAGGAGGCVGTCCTTGACAGTGGACACCTTGGAG  AGCGTCAGGAGGCVGTCCTTGACAGTGGACACCTTGGAG
( V代^ A/C/G )  (V generation ^ A/C/G)
(2)购置 DNA聚合酶: fo DNA聚合酶置于容器;  (2) purchasing DNA polymerase: fo DNA polymerase is placed in a container;
(3) 配制反应液和引物: 反应液含有 2mmol/LdNTP、 25mmol/L Tris-CK 12.5mmol/L KC1、 12.5mmol/L (NH4) 2S04、 lOmmol/L MgS04、 0.125 体积% TritonX-100, lmol/L甜菜碱、 内引物 FIP/BIP各 0.2 mol/L和外引物 F3/B3 各 0.25 mol/L, 置于容器; (3) Preparation of reaction solution and primer: The reaction solution contained 2 mmol/L dNTP, 25 mmol/L Tris-CK 12.5 mmol/L KC1, 12.5 mmol/L (NH 4 ) 2 S0 4 , 10 mmol/L MgS0 4 , 0.125 vol% TritonX -100, lmol/L betaine, internal primer FIP/BIP 0.2 mol/L and external primer F3/B3 each 0.25 mol/L, placed in a container;
( 4 )配制样品预处理液: 样品预处理液含有 20 mmol/L Tris- HC1 ( pH 8.0 )、 2 mmol/L EDTA和 1.2体积% Triton X-100, 置于容器;  (4) Preparing sample pretreatment liquid: The sample pretreatment liquid contains 20 mmol/L Tris-HC1 (pH 8.0), 2 mmol/L EDTA and 1.2% by volume Triton X-100, and placed in a container;
(5) 购置稳定液: 石蜡油, 置于容器;  (5) Purchase stabilizer: paraffin oil, placed in a container;
(6)购置显色液: SYBRGreenl, 置于容器; (7)提取阳性对照: 提取 BCG基因组 DNA, 置于容器; (6) Purchase coloring solution: SYBRGreenl, placed in a container; (7) Extracting the positive control: extracting the BCG genomic DNA and placing it in a container;
( 8 )将上述 7个容器装成试剂盒, 封装。  (8) The above seven containers are packed into a kit and packaged.
制备工艺筒述如下:  The preparation process is as follows:
1、 将内引物 FIP/BIP和外引物 F3/B3合成纯化后, 定量配制, 浓度检测, 抽样质检;  1. After the internal primer FIP/BIP and the external primer F3/B3 are synthesized and purified, quantitative preparation, concentration detection, and sampling quality inspection;
2、 将上述(2)〜 (4) 步骤配制的液体无菌分装, 并按照实验用进行浓度 确定, 抽样质检;  2. The liquid prepared in the above steps (2) to (4) is aseptically packaged, and the concentration is determined according to the experiment, and the sample quality inspection is performed;
3、 将稳定液分装, 抽样质检;  3. Packing the stable liquid and sampling the quality inspection;
4、 将阳性对照标本制备, 分装, 抽样质检;  4. Prepare the positive control specimens, sub-package, and sample quality inspection;
5、 组装试剂盒。 实施例 2 试剂盒的制备  5. Assemble the kit. Example 2 Preparation of the kit
( 1 )按以下序列经 DNA合成仪合成寡聚脱氧核酸引物:  (1) Synthesis of oligodeoxynucleotide primers by DNA synthesizer according to the following sequence:
夕卜引物 F3: (SEQIDNO 1 )  夕卜引器 F3: (SEQIDNO 1 )
TCATCACCGTCGAGGAGTC  TCATCACCGTCGAGGAGTC
外引物 B3: (SEQIDNO 2)  External primer B3: (SEQIDNO 2)
CGGCTCCGATGACCTTCTC  CGGCTCCGATGACCTTCTC
内引物 FIP: (SEQIDNO 3) 内引物 BIP: (SEQIDNO 4)  Internal primer FIP: (SEQIDNO 3) Internal primer BIP: (SEQIDNO 4)
AGCGTCAGGAGGCVGTCCTTGACAGTGGACACCTTGGAG  AGCGTCAGGAGGCVGTCCTTGACAGTGGACACCTTGGAG
( V代^ A/C/G )  (V generation ^ A/C/G)
(2)购置 DNA聚合酶: fo DNA聚合酶置于容器;  (2) purchasing DNA polymerase: fo DNA polymerase is placed in a container;
( 3 ) 配制反应液和引物: 反应液含有 1.6mmol/LdNTP、 20mmol/L Tris-Cl、 1 Ommol/L KCl、 1 Ommol/L ( NH4 ) 2S04、 8mmol/L MgS04、0.1体积% TritonX- 100、 0.8mol/L甜菜碱、 内引物 FIP/BIP各 0.2 mol/L和外引物 F3/B3各 0.25 mol/L, 置 卞谷 ; ( 4 )配制样品预处理液: 样品预处理液含有 10 mmol/L Tris- HC1 ( pH 8.0 )、 mmol/L EDTA和 1.0体积% Triton X- 100 , 置于容器; (3) Preparation of reaction solution and primer: The reaction solution contains 1.6 mmol/L dNTP, 20 mmol/L Tris-Cl, 1 Ommol/L KCl, 1 Ommol/L (NH 4 ) 2 S0 4 , 8 mmol/L MgS0 4 , 0.1 volume % TritonX-100, 0.8 mol/L betaine, internal primer FIP/BIP 0.2 mol/L and external primer F3/B3 each 0.25 mol/L, placed in the valley; (4) Preparing sample pretreatment liquid: The sample pretreatment liquid contains 10 mmol/L Tris-HCl (pH 8.0), mmol/L EDTA and 1.0% by volume Triton X-100, and placed in a container;
(5) 购置稳定液: 石蜡油, 置于容器;  (5) Purchase stabilizer: paraffin oil, placed in a container;
(6) 购置显色液: EVAGreenl, 置于容器;  (6) Purchase coloring solution: EVAGreenl, placed in a container;
(7)提取阳性对照: 提取 BCG基因组 DNA, 置于容器;  (7) Extracting the positive control: extracting the BCG genomic DNA and placing it in a container;
( 8 )将上述 7个容器装成试剂盒, 封装。  (8) The above seven containers are packed into a kit and packaged.
其他同实施例 1。 实施例 3 试剂盒的制备  Others are the same as in the first embodiment. Example 3 Preparation of a kit
其他条件与实施例 1相同, 其不同仅在于步骤(1) 中的引物为:  The other conditions are the same as in the first embodiment except that the primers in the step (1) are:
外引物 F3,: ( SEQ ID NO 5 )  External primer F3,: ( SEQ ID NO 5 )
AGTCCATCGGTGACCTGATC  AGTCCATCGGTGACCTGATC
外引物 B3,: ( SEQ ID NO 6 )  External primer B3,: ( SEQ ID NO 6 )
AGGACCGCCTCCTGAC  AGGACCGCCTCCTGAC
内引物 FIP,: ( SEQ ID NO 7 )  Internal primer FIP,: ( SEQ ID NO 7 )
GGTGTTGGACTCCTCGACGGGCCGAGGCGATGGACAA  GGTGTTGGACTCCTCGACGGGCCGAGGCGATGGACAA
内引物 BIP,: ( SEQ ID NO 8 )  Internal primer BIP,: ( SEQ ID NO 8 )
GCAGCTCGAGCTCACCGAGCGGGTCGGTCACGAAGT 实施例 4 试剂盒的制备  GCAGCTCGAGCTCACCGAGCGGGTCGGTCACGAAGT Example 4 Preparation of the kit
其他条件与实施例 1相同, 其不同仅在于步骤(1) 中的引物为:  The other conditions are the same as in the first embodiment except that the primers in the step (1) are:
外引物 F3": (SEQIDNO 1 )  External primer F3": (SEQIDNO 1 )
TCATCACCGTCGAGGAGTC  TCATCACCGTCGAGGAGTC
外引物 B3": (SEQIDNO 9)  External primer B3": (SEQIDNO 9)
AGCGGCAGCAGRTCCT  AGCGGCAGCAGRTCCT
内引物 FIP": (SEQIDNO 10) 内引物 BIP": (SEQIDNO 4) AGCGTCAGGAGGCVGTCCTTGACAGTGGACACCTTGGAG Internal primer FIP": (SEQIDNO 10) internal primer BIP": (SEQIDNO 4) AGCGTCAGGAGGCVGTCCTTGACAGTGGACACCTTGGAG
( V代^ A/C/G, R代表 A/G ) 实施例 5 分枝杆菌属检测试剂盒的应用 一、 方法和材料  (V generation ^ A/C/G, R stands for A/G) Example 5 Application of Mycobacterium detection kit I. Methods and materials
1、 菌株 1. Strain
本发明采用菌株有 29株, 主要来源于美国标准生物品收藏中心、 中国药品 生物制品检定所。 详见表 1。  The invention adopts 29 strains, mainly from the American Standard Biological Collection Center and the China National Institute for the Control of Pharmaceutical and Biological Products. See Table 1 for details.
表 1 菌株名称及来源  Table 1 Name and source of the strain
菌株来源 菌株及编号  Strain source strain and number
美国标准 结核分枝杆菌复合群 4株  American Standard Mycobacterium tuberculosis complex 4 strains
生物品收 M.tuberculosis H37Rv ( ATCC 27294 ), M.microti ( ATCC 19422 ), 藏 中 心 M.africanum ( ATCC 25420 )、 M.bovis ( ATCC 19210 )  Biological products M.tuberculosis H37Rv ( ATCC 27294 ), M.microti ( ATCC 19422 ), Tibetan center M.africanum ( ATCC 25420 ), M.bovis ( ATCC 19210 )
( ATCC ) 非结核分枝杆菌 17株  (ATCC) non-tuberculous mycobacteria 17 strains
M.kansasii ( ATCC 12478 )、 M.intracellulare ( ATCC 13950 )、 M.kansasii (ATCC 12478), M. intracellulare (ATCC 13950),
M.chelonae( ATCC 14472 ), M.fortuitum( ATCC 6841 ), M.gordonae ( ATCC 14470 ), M.marinum ( ATCC 927 ), M.smegmatis ( ATCCM.chelonae ( ATCC 14472 ), M.fortuitum ( ATCC 6841 ), M. gordonae ( ATCC 14470 ), M.marinum ( ATCC 927 ), M.smegmatis ( ATCC
19420 ), M.terrae( ATCC 19619 ), M.avium( ATCC 25291 ), M.phlei ( ATCC 11758 )、 M.scrofulaceum ( ATCC 19981 )、 M.abscessus ( ATCC 19977 ), M.ulcerans ( ATCC 19423 )、 M.shimoidei ( ATCC19420 ), M.terrae ( ATCC 19619 ), M.avium ( ATCC 25291 ), M.phlei ( ATCC 11758 ), M.scrofulaceum ( ATCC 19981 ), M.abscessus ( ATCC 19977 ), M.ulcerans ( ATCC 19423 ) , M.shimoidei (ATCC
27962 )、 M.asiaticum ( ATCC 25276 )、 M.xenopi ( ATCC 19250 )、27962 ), M.asiaticum ( ATCC 25276 ), M.xenopi ( ATCC 19250 ),
M.gastri ( ATCC 15754 ) M.gastri ( ATCC 15754 )
中国药品  Chinese medicine
生物制品 M.bovis BCG  Biological products M.bovis BCG
检定所  Certification institute
其它菌株 金黄色葡萄球菌、 志贺氏菌、 副溶血弧菌、 沙门氏菌、 单核增生 李斯特菌、 小肠结肠炎耶尔森氏菌、 乙型溶血链球菌各 1株。 Other strains of Staphylococcus aureus, Shigella, Vibrio parahaemolyticus, Salmonella, mononuclear hyperplasia Listeria monocytogenes, Yersinia enterocolitica, and one strain of Streptococcus hemolyticus.
2、 样品处理(模板 DNA提取) 2, sample processing (template DNA extraction)
( 1 )吸取培养菌液 lmL, 12000rpm离心 2min, 获得菌体沉淀;  (1) Aspirate the culture bacterial solution lmL, centrifuge at 12000 rpm for 2 min to obtain a bacterial cell pellet;
( 2 )在上述菌体沉淀中加入 ΙΟΟμΙ DNA提取液 I, 沸水浴 lOmin, 加入 12.5μΙ^ DNA提取液 II, 稍混匀; 12000rpm离心 2min, 上清即为即为样品模板 DNA。  (2) Add ΙΟΟμΙ DNA extract I to the above-mentioned cell pellet, boil water bath for 10 min, add 12.5 μΙ^ DNA extract II, mix slightly; centrifuge at 12000 rpm for 2 min, the supernatant is the sample template DNA.
3、 环介导恒温扩增技术的反应过程 3. The reaction process of ring-mediated constant temperature amplification technology
( 1 )在 20(^L反应管配制反应体系: 反应液和引物共 22 L, fo DNA聚合酶 0.5μΙ ( 4U ), 稳定液 30μΙ^, 模板 DNA 2.5 L。  (1) Prepare the reaction system in 20 (^L reaction tube: 22 L of reaction solution and primer, 0.5 μΙ (4U) of fo DNA polymerase, 30μΙ of stable solution, 2.5 L of template DNA.
( 2 )将配制好的反应管于 65°C恒温反应 1小时。  (2) The prepared reaction tube was reacted at 65 ° C for 1 hour at a constant temperature.
4、 反应后处理 4, post-reaction treatment
向上述反应产物中加入 2 L SYBR Green I, 混匀, 同时也向阳性对照管 ( BCG基因组 DNA )和阴性对照管 (去离子水) 中加入 S YBR Green I混匀, 若反应管与阳性对照管一样显现绿色则为阳性, 若反应管与阴性对照管一样显 现橙色则为阴性。  Add 2 L SYBR Green I to the above reaction product, mix, and also add S YBR Green I to the positive control tube (BCG genomic DNA) and the negative control tube (deionized water), if the reaction tube and the positive control If the tube appears green, it is positive. If the reaction tube is orange as the negative control tube, it is negative.
5、 电泳 5, electrophoresis
配制 0.2%琼脂糖凝胶电泳。 以 SYBR Green I作为染料进行显色反应观察结 果。  Prepare 0.2% agarose gel electrophoresis. The color reaction was observed with SYBR Green I as a dye.
6、 特异度试验 6, specificity test
纯菌株 LAMP检测 用 LAMP方法对 29株细菌进行扩增, 根据显色反应观 察结果, 绿色为阳性, 橙色阴性, 验证方法特异性。  Pure strain LAMP detection 29 strains of bacteria were amplified by the LAMP method. According to the results of the color reaction, green was positive, orange was negative, and the verification method was specific.
7、 灵敏度试验 7, sensitivity test
将 M.bovis BCG精提核酸, 用 TE做 10倍倍比连续梯度稀释至 10·1(), 进行 LAMP检测。 8、 重复性试验 特异度试验和灵敏度试验分别重复 2次。 二、 结果 1、 特异度试验 The M. bovis BCG was extracted from the nucleic acid, and the LAMP assay was performed by serially diluting to 10· 1() with a 10-fold ratio of TE. 8. The repeatability test specificity test and sensitivity test were repeated twice. Second, the results 1, specificity test
4株结核分枝杆菌复合群检测结果阳性, 17株非结核分枝杆菌检测结果阳 性, 结核疫苗 BCG阳性, 7株非分枝杆菌均为阴性, 如表 2所示。 结果显示试 剂盒具有高特异性。  The results of 4 strains of Mycobacterium tuberculosis complex were positive, 17 strains of non-tuberculous mycobacteria were positive, tuberculosis vaccine BCG was positive, and 7 strains of non-mycobacteria were negative, as shown in Table 2. The results show that the kit has high specificity.
表 2检测结果  Table 2 test results
检测样品 结果  Test sample result
M.tuberculosis H37Rv ( ATCC 27294 ) 阳性  M.tuberculosis H37Rv ( ATCC 27294 ) positive
M.microti ( ATCC 19422 ) 阳性  M.microti ( ATCC 19422 ) positive
M.africanum ( ATCC 25420 ) 阳性  M.africanum ( ATCC 25420 ) positive
M.bovis ( ATCC 19210 ) 阳性  M.bovis ( ATCC 19210 ) positive
M.kansassi ( ATCC 12478 ) 阳性  M.kansassi ( ATCC 12478 ) positive
M.intracellulare ( ATCC 13950 ) 阳性  M.intracellulare ( ATCC 13950 ) positive
M.chelonae ( ATCC 14472 ) 阳性  M.chelonae ( ATCC 14472 ) positive
M.fortuitum ( ATCC 6481 ) 阳性  M.fortuitum ( ATCC 6481 ) positive
M.gordonae ( ATCC 14470 ) 阳性  M.gordonae ( ATCC 14470 ) positive
M.marinum ( ATCC 927 ) 阳性  M.marinum ( ATCC 927 ) positive
M.smegmatis ( ATCC 19420 ) 阳性  M.smegmatis ( ATCC 19420 ) positive
M.terrae ( ATCC 19619 ) 阳性  M.terrae ( ATCC 19619 ) positive
M.avium ( ATCC 25291 ) 阳性  M.avium ( ATCC 25291 ) positive
M.phlei ( ATCC 11758 ) 阳性  M.phlei ( ATCC 11758 ) positive
M.scrofulaceum ( ATCC 19981 ) 阳性  M.scrofulaceum ( ATCC 19981 ) positive
M.abscessus ( ATCC 19977 ) 阳性  M.abscessus ( ATCC 19977 ) positive
M.ulcerans ( ATCC 19423 ) 阳性 M.shimoidei ( ATCC 27962 ) 阳性 M.ulcerans ( ATCC 19423 ) positive M.shimoidei ( ATCC 27962 ) positive
M.asiaticum ( ATCC 25276 ) 阳性  M.asiaticum ( ATCC 25276 ) positive
M.xenopi ( ATCC 19250 ) 阳性  M.xenopi ( ATCC 19250 ) positive
M.gastri ( ATCC 15754 ) 阳性  M.gastri ( ATCC 15754 ) positive
M.bovis BCG 阳性  M.bovis BCG positive
金黄色葡萄球菌 阴性  Staphylococcus aureus negative
志贺氏菌 阴性  Shigella negative
副溶血孤菌 阴性  Deputy hemolytic bacterium
沙门氏菌 阴性  Salmonella negative
单核增生李斯特菌 阴性  Listeria monocytogenes negative
小肠结肠炎耶尔森氏菌 阴性  Yersinia enterocolitica
乙型溶血链球菌 阴性  Type B hemolytic streptococcus negative
阳性对照 阳性  Positive control
阴性对照 阴性  Negative control negative
2、 灵敏度试验 2, sensitivity test
细菌原液浓度为 1.26xl06CFU/mL , LAMP方法可检测到第 4个稀释度, 为 1.26xl02CFU/mL。 The concentration of the bacterial stock solution was 1.26× 10 6 CFU/mL, and the fourth dilution was detected by the LAMP method, which was 1.26×10 2 CFU/mL.
电泳结果也符合上述结果。  The electrophoresis results also met the above results.
3、 重复性试验 3. Repeatability test
特异度试验重复两次, 结果一致。 灵敏度试验重复两次, 数量级一致。 实施例 6 采用反应管的分枝杆菌属检测试剂盒 本实施例的分枝杆菌属检测试剂盒, 采用的试剂和引物与实施例 1 相同, 试剂盒还包括反应管, 反应管由管体和管盖两部分组成, 管体内腔的下部设有 将其分隔成 A、 B两个空腔的纵向延伸的隔板, 其中: 空腔 A内装有 22.0μ 的 LAMP反应液和 0.5μΙ^的 Bst DNA聚合酶, 液体上层由石蜡封存; 空腔 B内装 有 2.0μΙ^的 LAMP反应显色液,液体上层也由石蜡封存,将该反应管 -20 °C保存。 本实施例采用反应管作为容器, 对分枝杆菌属进行 LAMP检测, 同时设有 阳性对照组和阴性对照组, 具体包括如下步骤: 取上述制备的反应管三支, 采用移液枪分别加入阴性对照样品、 待检测样 品和阳性对照样品各 2.5μ ,加样时枪头穿透保护液层,样品加至反应管 Α腔内, 盖紧管盖并做好标记, 移至反应区。 将上述反应管均于 65 °C恒温反应 lh。 反应结束, 将反应管倒置甩动 1次, 再正置甩动 1次, 使工作液与显色液 充分混合均匀后观察。 若反应管与阳性对照管一样显现绿色则为阳性, 若反应管与阴性对照管一 样显现橙色则为阴性。 在 LAMP反应过程中, 显色液与工作液密封状态好, 没有发生互相泄露的 情况, 后期显色反应时, 倒置甩动操作使得显色液和工作液混合, 显色结果清 The specificity test was repeated twice and the results were consistent. The sensitivity test was repeated twice, in the same order of magnitude. Example 6 Mycobacterium detection kit using a reaction tube The Mycobacterium detection kit of the present embodiment has the same reagents and primers as in Example 1, and the reagent cartridge further includes a reaction tube, and the reaction tube is composed of a tube body and The tube cover is composed of two parts, and the lower part of the inner cavity of the tube is provided with a longitudinally extending partition which divides the two cavities into A and B, wherein: the cavity A is filled with 22.0μ The LAMP reaction solution and 0.5 μM of Bst DNA polymerase, the upper layer of the liquid is sealed by paraffin; the cavity B contains 2.0 μM of LAMP reaction coloring solution, and the upper liquid layer is also sealed by paraffin, and the reaction tube is stored at -20 ° C. . In this embodiment, the reaction tube is used as a container, and the LAMP test is performed on the Mycobacterium, and the positive control group and the negative control group are provided at the same time, and the following steps are specifically included: The three reaction tubes prepared above are taken, and the pipettes are respectively added to the negative cells. The control sample, the sample to be tested and the positive control sample each are 2.5μ. When the sample is applied, the tip of the sample penetrates the protective layer, and the sample is added into the cavity of the reaction tube. The tube cap is tightly covered and marked, and moved to the reaction zone. The above reaction tubes were all reacted at 65 ° C for 1 h. After the reaction was completed, the reaction tube was inverted and shaken once, and then placed upright once, and the working solution and the color developing solution were thoroughly mixed and observed. If the reaction tube is green as the positive control tube, it is positive, and if the reaction tube is orange as the negative control tube, it is negative. During the LAMP reaction process, the color developing solution and the working fluid are in a sealed state, and no mutual leakage occurs. In the later color reaction, the inverted turbulent operation causes the coloring liquid and the working fluid to be mixed, and the coloration result is clear.
最后所应当说明的是, 以上实施例仅用以说明本发明的技术方案而非对本 发明保护范围的限制, 尽管参照较佳实施例对本发明作了详细说明, 本领域的 普通技术人员应当理解, 可以对本发明的技术方案进行修改或者等同替换, 而 不脱离本发明技术方案的实质和范围。 SEQUENCE LISTING It should be noted that the above embodiments are only intended to illustrate the technical solutions of the present invention, and are not intended to limit the scope of the present invention. The technical solutions of the present invention may be modified or equivalently substituted without departing from the spirit and scope of the technical solutions of the present invention. SEQUENCE LISTING
<110> 广州华峰生物科技有限公司 <110> Guangzhou Huafeng Biotechnology Co., Ltd.
<120> 分枝杆菌属检测试剂盒及其使用方法 <120> Mycobacterium detection kit and method of use thereof
<160> 10 <160> 10
<170> Patentln version 3.3 <170> Patentln version 3.3
<210> 1 <210> 1
<211> 19  <211> 19
<212> DNA  <212> DNA
<213> 人工合成  <213> Synthetic
<400> 1 <400> 1
tcatcaccgt cgaggagtc 19 Tcatcaccgt cgaggagtc 19
<210> 2 <210> 2
<211> 19  <211> 19
<212> DNA  <212> DNA
<213> 人工合成  <213> Synthetic
<400> 2 <400> 2
cggctccgat gaccttctc 19 Cggctccgat gaccttctc 19
<210> 3 Λ3Η21 <> <210> 3 Λ3Η21 <>
Figure imgf000018_0001
gggggggacaac accattt gggg accac caccacc0ttt 4
Figure imgf000018_0001
Gggggggacaac accattt gggg accac caccacc0ttt 4
02114 <> gggg g accacaccrtt 02114 <> Gggg g accacaccrtt
Figure imgf000019_0001
Figure imgf000019_0001
<> <>
0 ggggggggaccccac 37ttt tt 0 ggggggggaccccac 37ttt tt
<> <>
gggg aacccc ccac 6tt 1 0064 <>
Figure imgf000020_0001
ggg ggggggg ccacaaacccca accac caccacc0tttttt 4
Gggg aacccc ccac 6tt 1 0064 <>
Figure imgf000020_0001
Ggg ggggggg ccacaaacccca accac caccacc0tttttt 4
00211 <>  00211 <>

Claims

权利要求书 Claim
1. 一种分枝杆菌属检测试剂盒, 其特征在于, 所述的分枝杆菌属检测试剂 盒包括以分枝杆菌属的 hsp65基因为靶基因、基于环介导恒温扩增技术设计的两 对引物: 内引物 FIP/BIP和外引物 F3/B3 , 所述的两对引物为  A Mycobacterium detection kit, characterized in that the Mycobacterium detection kit comprises two molecules designed based on a loop-mediated constant temperature amplification technique using a hsp65 gene of Mycobacterium as a target gene. For primers: internal primer FIP/BIP and external primer F3/B3, the two pairs of primers are
外引物 F3:  External primer F3:
TCATCACCGTCGAGGAGTC  TCATCACCGTCGAGGAGTC
外引物 B3:  External primer B3:
CGGCTCCGATGACCTTCTC  CGGCTCCGATGACCTTCTC
内引物 FIP: 内引物 BIP:  Internal primer FIP: Internal primer BIP:
AGCGTCAGGAGGCVGTCCTTGACAGTGGACACCTTGGAG;  AGCGTCAGGAGGCVGTCCTTGACAGTGGACACCTTGGAG;
 Or
外引物 F3':  External primer F3':
AGTCCATCGGTGACCTGATC  AGTCCATCGGTGACCTGATC
外引物 B3':  External primer B3':
AGGACCGCCTCCTGAC  AGGACCGCCTCCTGAC
内引物 FIP':  Internal primer FIP':
GGTGTTGGACTCCTCGACGGGCCGAGGCGATGGACAA  GGTGTTGGACTCCTCGACGGGCCGAGGCGATGGACAA
内引物 ΒΙΡ':  Internal primer ΒΙΡ':
GCAGCTCGAGCTCACCGAGCGGGTCGGTCACGAAGT;  GCAGCTCGAGCTCACCGAGCGGGTCGGTCACGAAGT;
 Or
外引物 F3":  External primer F3":
TCATCACCGTCGAGGAGTC  TCATCACCGTCGAGGAGTC
外引物 B3":  External primer B3":
AGCGGCAGCAGRTCCT  AGCGGCAGCAGRTCCT
内引物 FIP": 内引物 BIP": Internal primer FIP": Internal primer BIP":
AGCGTCAGGAGGCVGTCCTTGACAGTGGACACCTTGGAG;  AGCGTCAGGAGGCVGTCCTTGACAGTGGACACCTTGGAG;
其中, V代^ A/C/G, R代表 A/G。  Among them, V generation ^ A / C / G, R represents A / G.
2. 根据权利要求 1所述的分枝杆菌属检测试剂盒, 其特征在于, 所述的分 枝杆菌属检测试剂盒还包括 fo DNA聚合酶、 反应液、 稳定液、 样品预处理液、 显色液和阳性对照液。 The Mycobacterium detection kit according to claim 1, wherein the Mycobacterium detection kit further comprises a fo DNA polymerase, a reaction solution, a stabilizing solution, a sample pretreatment liquid, and a display Color solution and positive control solution.
3. 根据权利要求 2所述的分枝杆菌属检测试剂盒, 其特征在于, The Mycobacterium detection kit according to claim 2, wherein
所述的 fo DNA聚合酶: 酶浓度 4-10 Ό/μΙ;  The fo DNA polymerase: the enzyme concentration is 4-10 Ό/μΙ;
所述的反应液含: 1.6 ~ 2mmol/L dNTP、 20 ~ 25mmol/L Tris-HCl、 10 ~ 12.5mmol/L KC1、 10 ~ 12.5mmol/L ( NH4 ) 2S04、 8 ~ lOmmol/L MgS04、 0.1 ~ 0.125体积% TritonX-100 , 0.8 ~ lmol/L甜菜碱; The reaction solution contains: 1.6 ~ 2mmol / L dNTP, 20 ~ 25mmol / L Tris-HCl, 10 ~ 12.5mmol / L KC1, 10 ~ 12.5mmol / L (NH 4 ) 2 S0 4 , 8 ~ lOmmol / L MgS0 4 , 0.1 ~ 0.125 vol% TritonX-100, 0.8 ~ lmol / L betaine;
所述的样品预处理液含: 10 ~ 20 mmol/L pH 8.0的 Tris- HC1、 1 ~ 2 mmol/L EDTA和 1 ~ 1.2体积% Triton X- 100;  The sample pretreatment liquid comprises: 10 ~ 20 mmol / L pH 8.0 Tris-HC1, 1 ~ 2 mmol / L EDTA and 1 ~ 1.2 vol% Triton X-100;
所述的显色液为 SYBR Green I或 Eva Green;  The color developing solution is SYBR Green I or Eva Green;
所述稳定液为石蜡油;  The stabilizing liquid is paraffin oil;
所述的阳性对照为 BCG基因组 DNA;  The positive control is BCG genomic DNA;
所述的内引物 FIP/BIP各为 0.2 ~ 0.25 mol/L,外引物 F3/B3的浓度各为 1.2 ~ 2.0 mol/L。  The internal primers FIP/BIP are each 0.2 to 0.25 mol/L, and the external primers F3/B3 are each 1.2 to 2.0 mol/L.
4. 根据权利要求 3所述的分枝杆菌属检测试剂盒, 其特征在于, The Mycobacterium detection kit according to claim 3, wherein
所述的 fo DNA聚合酶: 酶浓度 8 U/ L;  The fo DNA polymerase: enzyme concentration 8 U / L;
所述的反应液含: 2mmol/L dNTP、 25mmol/L Tris-HCl、 12.5mmol/L KC1、 12.5mmol/L ( NH4 ) 2S04 , lOmmol/L MgS04、 0.125体积%1¾ 01^-100、 lmol/L甜菜碱; The reaction solution contains: 2 mmol/L dNTP, 25 mmol/L Tris-HCl, 12.5 mmol/L KC1, 12.5 mmol/L (NH 4 ) 2 S0 4 , 10 mmol/L MgS0 4 , 0.125 vol% 13⁄4 01^- 100, lmol / L betaine;
所述的样品预处理液含: 20 mmol/L pH 8.0的 Tris-HCl、 2 mmol/L EDTA和 The sample pretreatment liquid contains: 20 mmol/L Tris-HCl, pH 8.0, 2 mmol/L EDTA, and
1.2体积% Triton X- 100 ; 1.2% by volume Triton X-100;
所述的显色液为 SYBR Green I;  The color developing solution is SYBR Green I;
所述的内引物 FIP/BIP的浓度各为 0.2 mol/L ;  The concentration of the internal primers FIP/BIP is 0.2 mol/L;
所述的外引物 F3/B3的浓度各为 1.6 mol/L。  The concentration of the external primer F3/B3 was 1.6 mol/L each.
5. 根据权利要求 2、 3或 4所述的分枝杆菌属检测试剂盒, 其特征在于, 所 述的分枝杆菌属检测试剂盒还包括反应管, 所述的反应管由管体和管盖两部分 组成, 管体内腔的下部设有将其分隔成 A、 B两个空腔的纵向延伸的隔板。 The Mycobacterium detection kit according to claim 2, 3 or 4, wherein the Mycobacterium detection kit further comprises a reaction tube, and the reaction tube is composed of a tube and a tube The cover is composed of two parts, and the lower part of the inner cavity of the tube is provided with a longitudinally extending partition which divides it into two cavities A and B.
6. 根据权利要求 5所述的分枝杆菌属检测试剂盒, 其特征在于, 所述的 A、 B 两个空腔中分别装有工作液或显色液, 两个空腔中的液体上层均由稳定液封 存, 所述工作液为反应液和 Bst DNA聚合酶的混合而成。 The Mycobacterium detection kit according to claim 5, wherein the two cavities A and B are respectively provided with a working fluid or a color developing liquid, and the liquid upper layer in the two cavities Both are sealed by a stabilizing liquid, which is a mixture of a reaction solution and Bst DNA polymerase.
7. 一种使用如权利要求 2所述的分枝杆菌属检测试剂盒的方法, 其特征在 于, 该方法包括如下步骤: A method of using the Mycobacterium detection kit according to claim 2, wherein the method comprises the steps of:
( 1 )将待测样品离心, 去上清, 得到沉淀;  (1) centrifuging the sample to be tested, removing the supernatant to obtain a precipitate;
( 2 )将步骤(1 ) 的沉淀加入样品预处理液, 混合均勾, 沸水浴灭活后冰 上冷却, 高速离心, 上清即为样品模板 DNA;  (2) adding the precipitate of step (1) to the sample pretreatment liquid, mixing and hooking, inactivation of the boiling water bath, cooling on ice, centrifugation at high speed, and the supernatant is the sample template DNA;
( 3 )在反应容器中加入 Bst DNA聚合酶 0.9 ~ 1.8体积份数、 反应液 38~40 体积份数、 稳定液 52 ~ 54.5体积份数、 样品模板 DNA 4.5-9体积份数、 内引物 FIP/BIP各 2体积份数、 外引物 F3/B3各 4体积份数, 恒温反应;  (3) Adding 0.9 to 1.8 parts by volume of Bst DNA polymerase, 38 to 40 parts by volume of the reaction solution, 52 to 54.5 parts by volume of the stable solution, 4.5-9 parts by volume of the sample template DNA, and FIP of the internal primer in the reaction vessel /BIP 2 parts by volume, 4 parts by volume of external primer F3/B3, constant temperature reaction;
( 4 )在上述反应容器和阳性对照中分别加入显色液, 混匀, 样品组显色与 对照组相同则为阳性, 否则为阴性;  (4) adding a coloring solution to the above reaction container and the positive control, respectively, and mixing, and the color of the sample group is positive as the control group, otherwise it is negative;
所述步骤( 3 )中的内引物 FIP/BIP和外引物 F3/B3为以分枝杆菌属的 hsp65 基因为靶基因、 基于环介导恒温扩增技术设计的两对引物。  The inner primer FIP/BIP and the outer primer F3/B3 in the step (3) are two pairs of primers designed based on the hsp65 gene of Mycobacterium and designed based on loop-mediated constant temperature amplification technology.
8. 根据权利要求 7所述的使用分枝杆菌属检测试剂盒的方法,其特征在于, 所述步骤( 3 )中, 恒温反应的反应条件为温度 63 ~ 65 °C ,反应时间 45 ~ 90min。 The method according to claim 7, wherein in the step (3), the reaction condition of the constant temperature reaction is a temperature of 63 to 65 ° C, and a reaction time of 45 to 90 min. .
PCT/CN2013/083310 2012-09-19 2013-09-11 Mycobacterium detection kit and method of use thereof WO2014044142A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201210352230.5 2012-09-19
CN201210352230.5A CN102827944B (en) 2012-09-19 2012-09-19 Mycobacterium detection kit and using method thereof

Publications (1)

Publication Number Publication Date
WO2014044142A1 true WO2014044142A1 (en) 2014-03-27

Family

ID=47331251

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2013/083310 WO2014044142A1 (en) 2012-09-19 2013-09-11 Mycobacterium detection kit and method of use thereof

Country Status (2)

Country Link
CN (2) CN103451309B (en)
WO (1) WO2014044142A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103451309B (en) * 2012-09-19 2015-11-18 广州华峰生物科技有限公司 Mycobacterium detection kit and using method thereof
CN103088139B (en) * 2013-01-28 2015-04-22 清华大学 Primer pair and standard substance for detecting mycobacteria and application thereof
CN116287324B (en) * 2022-09-20 2023-09-22 北京理工大学 Primer and kit for detecting bacillus spatially and application of primer and kit

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102827944A (en) * 2012-09-19 2012-12-19 广州华峰生物科技有限公司 Mycobacterium detection kit and using method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101157954A (en) * 2007-09-13 2008-04-09 中华人民共和国徐州出入境检验检疫局 Concretion mycobacterium nucleic acid screening method based on loop-mediated isothermal amplification technique
CN101935693B (en) * 2010-01-18 2012-03-28 广州华峰生物科技有限公司 Mycobacterium tuberculosis detection kit and use method thereof
CN101942508B (en) * 2010-05-18 2012-11-14 广州华峰生物科技有限公司 Escherichia coli detection kit and use method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102827944A (en) * 2012-09-19 2012-12-19 广州华峰生物科技有限公司 Mycobacterium detection kit and using method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MUKAI T. ET AL.: "Identification of Mycobacterium species by comparative analysis of the dnaA gene", FEMS MICROBIOL LETT, vol. 254, no. 2, January 2006 (2006-01-01), pages 232 - 239 *
TELENTI A. ET AL.: "Rapid Identification of Mycobacteria to the Species Level by Polymerase Chain Reaction and Restriction Enzyme Analysis", JOURNAL OF CLINICAL MICROBIOLOGY, FEBRUARY, vol. 31, no. 2, 1993, pages 175 - 178 *

Also Published As

Publication number Publication date
CN102827944B (en) 2014-07-23
CN102827944A (en) 2012-12-19
CN103451309B (en) 2015-11-18
CN103451309A (en) 2013-12-18

Similar Documents

Publication Publication Date Title
CA2895945C (en) Target capture system
US8975060B2 (en) Method for pretreatment of microbial samples
CN101935693B (en) Mycobacterium tuberculosis detection kit and use method thereof
CN102373273A (en) Kit for detecting nucleic acid of mycobacterium tuberculosis and method thereof
US11702647B2 (en) Method for pretreatment of microbial cells
JP6840207B2 (en) Compositions and Methods for Detection and Analysis of Mycobacterium Tubercrosis
AU2020102244A4 (en) Primer group, kit and detection method for rapidly detecting carbapenemases genes
US9707555B2 (en) Method for pretreatment of microbial samples
Brossier et al. Molecular detection methods of resistance to antituberculosis drugs in Mycobacterium tuberculosis
WO2014044142A1 (en) Mycobacterium detection kit and method of use thereof
CN101942508A (en) Escherichia coli detection kit and use method thereof
CN102719548B (en) Kit for detecting brucella and use method thereof
CN102286620A (en) Enterohemorrhagic E. coli stx2 gene detection kit and using method thereof
CN102251044A (en) Enterorrhagia colibacillus stx1 gene detection kit and application method thereof
CN101979660B (en) Brucella detection kit and using method thereof
CN101985658B (en) Loop-mediated isothermal amplification method for detecting anaplasma ovis pathogeny
KR101523877B1 (en) Methods for identification and detection of mycobacterium using real time polymerase chain reaction and melting curve analysis
KR101426119B1 (en) Methods for identification and detection of mycobacterium using real time polymerase chain reaction and melting curve analysis
CN109988856B (en) LAMP primer combination for detecting yersinia pneumocystis and application thereof
RU2455364C2 (en) Method of identifying mycobacteria by polymerase chain reaction
CN114187968A (en) Sterility detection method based on NGS technology
US9175354B2 (en) Detection of Salmonella enterica subspecies enterica serovar Enteritidis in food and environmental samples, methods and compositions therefor
RU2435852C1 (en) OLIGONUCLEOTIDE PRIMERS AND METHOD OF DETECTING DNA OF Mycobacterium paratuberculosis THAT IS PARATUBERCULOSIS AGENT BY METHOD OF POLYMERASE CHAIN REACTION (PCR)
CN110273015B (en) LAMP technology-based visual detection method for mycobacterium kansasii
Chitra et al. Diagnostic Performance of Polymerase Chain Reaction Targeting Insertion Sequence (IS6110) for the Detection of Extra Pulmonary Tuberculosis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13839544

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13839544

Country of ref document: EP

Kind code of ref document: A1